| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc50e3a94cfe165d9d6ef195089ba2a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ae260fb1f9722263bc5593e6f64844
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a64dbd398a42f84a42fe420a4a5533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_341098b2bb8c0d4e33f257332c45ff59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da906f3b14e7a86ae5ae9e8888f037fd |
| publicationDate |
2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1444253-B1 |
| titleOfInvention |
Pna-conjugates for treating chronic myeloid leukemia (cml) |
| abstract |
The invention relates to peptide nucleic acid (PNA) conjugates which inhibit the expression of the bcr/abl fusion gene characteristic of CML and are suited to treat chronic myeloid leukemia (CML). |
| priorityDate |
2001-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |